Selected research
Industry Research
Oral Soluble Film Industry Research Report 2026
Market perspective
The global Oral Soluble Film market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral Soluble Film is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral Soluble Film is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral Soluble Film is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral Soluble Film include Aavishkar, Adhex Pharma, Aquestive Therapeutics, Arx Pharma, BioDelivery(BDSI), Cure Pharmaceutical, IntelGenx Corp., LIVKON Pharmaceutical Pvt Ltd and LLS Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral Soluble Film market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Soluble Film Market by Company
Aavishkar
Adhex Pharma
Aquestive Therapeutics
Arx Pharma
BioDelivery(BDSI)
Cure Pharmaceutical
IntelGenx Corp.
LIVKON Pharmaceutical Pvt Ltd
LLS Health
Lohmann Therapie-Systeme
NAL Pharma
Shilpa Therapeutics
Tapemark
Umang
ZIM Laboratories
QQP
Xiamen LP Pharma
Top Pharm
Oral Soluble Film Segment by Type
Medikament Film
Health Products Film
Oral Soluble Film Segment by Application
Hospital and Clinic
E-commerce
Supermarket and Drug Store
Others
Oral Soluble Film Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Soluble Film market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Soluble Film and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Soluble Film.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Soluble Film manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Soluble Film by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Soluble Film in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medikament Film
- Health Products Film
Applications
- Hospital and Clinic
- E-commerce
- Supermarket and Drug Store
- Others
Companies covered
- Aavishkar
- Adhex Pharma
- Aquestive Therapeutics
- Arx Pharma
- BioDelivery(BDSI)
- Cure Pharmaceutical
- IntelGenx Corp.
- LIVKON Pharmaceutical Pvt Ltd
- LLS Health
- Lohmann Therapie-Systeme
- NAL Pharma
- Shilpa Therapeutics
- Tapemark
- Umang
- ZIM Laboratories
- QQP
- Xiamen LP Pharma
- Top Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral Soluble Film Market Size (2021-2032)
- 2.2.2 Global Oral Soluble Film Sales (2021-2032)
- 2.2.3 Global Oral Soluble Film Market Average Price (2021-2032)
- 2.3 Oral Soluble Film by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medikament Film
- 2.3.3 Health Products Film
- 2.4 Oral Soluble Film by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 E-commerce
- 2.4.4 Supermarket and Drug Store
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral Soluble Film Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral Soluble Film Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Oral Soluble Film Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral Soluble Film Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral Soluble Film Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral Soluble Film, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral Soluble Film, Product Type & Application
- 3.8 Global Manufacturers of Oral Soluble Film, Established Date
- 3.9 Global Oral Soluble Film Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aavishkar
- 4.1.1 Aavishkar Company Information
- 4.1.2 Aavishkar Business Overview
- 4.1.3 Aavishkar Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aavishkar Oral Soluble Film Product Portfolio
- 4.1.5 Aavishkar Recent Developments
- 4.2 Adhex Pharma
- 4.2.1 Adhex Pharma Company Information
- 4.2.2 Adhex Pharma Business Overview
- 4.2.3 Adhex Pharma Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Adhex Pharma Oral Soluble Film Product Portfolio
- 4.2.5 Adhex Pharma Recent Developments
- 4.3 Aquestive Therapeutics
- 4.3.1 Aquestive Therapeutics Company Information
- 4.3.2 Aquestive Therapeutics Business Overview
- 4.3.3 Aquestive Therapeutics Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Aquestive Therapeutics Oral Soluble Film Product Portfolio
- 4.3.5 Aquestive Therapeutics Recent Developments
- 4.4 Arx Pharma
- 4.4.1 Arx Pharma Company Information
- 4.4.2 Arx Pharma Business Overview
- 4.4.3 Arx Pharma Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Arx Pharma Oral Soluble Film Product Portfolio
- 4.4.5 Arx Pharma Recent Developments
- 4.5 BioDelivery(BDSI)
- 4.5.1 BioDelivery(BDSI) Company Information
- 4.5.2 BioDelivery(BDSI) Business Overview
- 4.5.3 BioDelivery(BDSI) Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BioDelivery(BDSI) Oral Soluble Film Product Portfolio
- 4.5.5 BioDelivery(BDSI) Recent Developments
- 4.6 Cure Pharmaceutical
- 4.6.1 Cure Pharmaceutical Company Information
- 4.6.2 Cure Pharmaceutical Business Overview
- 4.6.3 Cure Pharmaceutical Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cure Pharmaceutical Oral Soluble Film Product Portfolio
- 4.6.5 Cure Pharmaceutical Recent Developments
- 4.7 IntelGenx Corp.
- 4.7.1 IntelGenx Corp. Company Information
- 4.7.2 IntelGenx Corp. Business Overview
- 4.7.3 IntelGenx Corp. Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 IntelGenx Corp. Oral Soluble Film Product Portfolio
- 4.7.5 IntelGenx Corp. Recent Developments
- 4.8 LIVKON Pharmaceutical Pvt Ltd
- 4.8.1 LIVKON Pharmaceutical Pvt Ltd Company Information
- 4.8.2 LIVKON Pharmaceutical Pvt Ltd Business Overview
- 4.8.3 LIVKON Pharmaceutical Pvt Ltd Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 LIVKON Pharmaceutical Pvt Ltd Oral Soluble Film Product Portfolio
- 4.8.5 LIVKON Pharmaceutical Pvt Ltd Recent Developments
- 4.9 LLS Health
- 4.9.1 LLS Health Company Information
- 4.9.2 LLS Health Business Overview
- 4.9.3 LLS Health Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 LLS Health Oral Soluble Film Product Portfolio
- 4.9.5 LLS Health Recent Developments
- 4.10 Lohmann Therapie-Systeme
- 4.10.1 Lohmann Therapie-Systeme Company Information
- 4.10.2 Lohmann Therapie-Systeme Business Overview
- 4.10.3 Lohmann Therapie-Systeme Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lohmann Therapie-Systeme Oral Soluble Film Product Portfolio
- 4.10.5 Lohmann Therapie-Systeme Recent Developments
- 4.11 NAL Pharma
- 4.11.1 NAL Pharma Company Information
- 4.11.2 NAL Pharma Business Overview
- 4.11.3 NAL Pharma Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 NAL Pharma Oral Soluble Film Product Portfolio
- 4.11.5 NAL Pharma Recent Developments
- 4.12 Shilpa Therapeutics
- 4.12.1 Shilpa Therapeutics Company Information
- 4.12.2 Shilpa Therapeutics Business Overview
- 4.12.3 Shilpa Therapeutics Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shilpa Therapeutics Oral Soluble Film Product Portfolio
- 4.12.5 Shilpa Therapeutics Recent Developments
- 4.13 Tapemark
- 4.13.1 Tapemark Company Information
- 4.13.2 Tapemark Business Overview
- 4.13.3 Tapemark Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Tapemark Oral Soluble Film Product Portfolio
- 4.13.5 Tapemark Recent Developments
- 4.14 Umang
- 4.14.1 Umang Company Information
- 4.14.2 Umang Business Overview
- 4.14.3 Umang Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Umang Oral Soluble Film Product Portfolio
- 4.14.5 Umang Recent Developments
- 4.15 ZIM Laboratories
- 4.15.1 ZIM Laboratories Company Information
- 4.15.2 ZIM Laboratories Business Overview
- 4.15.3 ZIM Laboratories Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 ZIM Laboratories Oral Soluble Film Product Portfolio
- 4.15.5 ZIM Laboratories Recent Developments
- 4.16 QQP
- 4.16.1 QQP Company Information
- 4.16.2 QQP Business Overview
- 4.16.3 QQP Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 QQP Oral Soluble Film Product Portfolio
- 4.16.5 QQP Recent Developments
- 4.17 Xiamen LP Pharma
- 4.17.1 Xiamen LP Pharma Company Information
- 4.17.2 Xiamen LP Pharma Business Overview
- 4.17.3 Xiamen LP Pharma Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Xiamen LP Pharma Oral Soluble Film Product Portfolio
- 4.17.5 Xiamen LP Pharma Recent Developments
- 4.18 Top Pharm
- 4.18.1 Top Pharm Company Information
- 4.18.2 Top Pharm Business Overview
- 4.18.3 Top Pharm Oral Soluble Film Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Top Pharm Oral Soluble Film Product Portfolio
- 4.18.5 Top Pharm Recent Developments
5 Global Oral Soluble Film Market Scenario by Region
- 5.1 Global Oral Soluble Film Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral Soluble Film Sales by Region: 2021-2032
- 5.2.1 Global Oral Soluble Film Sales by Region: 2021-2026
- 5.2.2 Global Oral Soluble Film Sales by Region: 2027-2032
- 5.3 Global Oral Soluble Film Revenue by Region: 2021-2032
- 5.3.1 Global Oral Soluble Film Revenue by Region: 2021-2026
- 5.3.2 Global Oral Soluble Film Revenue by Region: 2027-2032
- 5.4 North America Oral Soluble Film Market Facts & Figures by Country
- 5.4.1 North America Oral Soluble Film Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral Soluble Film Sales by Country (2021-2032)
- 5.4.3 North America Oral Soluble Film Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Oral Soluble Film Market Facts & Figures by Country
- 5.5.1 Europe Oral Soluble Film Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral Soluble Film Sales by Country (2021-2032)
- 5.5.3 Europe Oral Soluble Film Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Oral Soluble Film Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral Soluble Film Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral Soluble Film Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral Soluble Film Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral Soluble Film Market Facts & Figures by Country
- 5.7.1 South America Oral Soluble Film Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral Soluble Film Sales by Country (2021-2032)
- 5.7.3 South America Oral Soluble Film Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Oral Soluble Film Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral Soluble Film Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral Soluble Film Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral Soluble Film Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Oral Soluble Film Sales by Type (2021-2032)
- 6.1.1 Global Oral Soluble Film Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Oral Soluble Film Sales Market Share by Type (2021-2032)
- 6.2 Global Oral Soluble Film Revenue by Type (2021-2032)
- 6.2.1 Global Oral Soluble Film Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral Soluble Film Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral Soluble Film Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral Soluble Film Sales by Application (2021-2032)
- 7.1.1 Global Oral Soluble Film Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Oral Soluble Film Sales Market Share by Application (2021-2032)
- 7.2 Global Oral Soluble Film Revenue by Application (2021-2032)
- 7.2.1 Global Oral Soluble Film Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral Soluble Film Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral Soluble Film Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral Soluble Film Value Chain Analysis
- 8.1.1 Oral Soluble Film Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral Soluble Film Production Mode & Process
- 8.2 Oral Soluble Film Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral Soluble Film Distributors
- 8.2.3 Oral Soluble Film Customers
9 Global Oral Soluble Film Analyzing Market Dynamics
- 9.1 Oral Soluble Film Industry Trends
- 9.2 Oral Soluble Film Industry Drivers
- 9.3 Oral Soluble Film Industry Opportunities and Challenges
- 9.4 Oral Soluble Film Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst